SK Group Considers Restructuring its Pharmaceutical and Biotech Portfolio
SEOUL, June 26 (Korea Bizwire) – SK Group, one of South Korea’s largest conglomerates, is reportedly reviewing its business portfolio across various sectors, including its pharmaceutical and biotech divisions. The move comes as part of the group’s broader strategy to streamline overlapping operations and secure liquidity for future investments. According to industry sources on June 25, [...]